Global Accelerator Network On Antibacterial Research Expands 26/02/2019 William New A network of life sciences organisations working together to address antibacterial resistance worldwide has expanded to now include 10 top organisations from six countries, according to CARB-X (Combating Antibiotic Resistant Bacteria), a US-based partnership investing hundreds of millions of dollars in R&D for antibacterial resistance over 5 years. Continue reading -> WHO Directors Meet With Staff This Week On Agency Transformation 25/02/2019 William New [Note: this meeting has been postponed until 6 March] Top officials from the World Health Organization will meet on 28 February will staff to discuss the transformation of the UN agency to a new structural alignment, according to an internal WHO email from the director general. Continue reading -> Suzette Kox Named Secretary General Of International Generic And Biosimilar Medicines Association 22/02/2019 William New The Geneva-based International Generic and Biosimilar medicines Association (IGBA) has named industry veteran Suzette Kox as secretary general. Image Credits: International Generic and Biosimilar medicines Association. Continue reading -> Report Details Health Crisis Hidden In Plastics Lifecycle 19/02/2019 William New A new report released today and authored by a range of environment and health groups pulls together research that "exposes distinct toxic risks plastic poses to human health at every stage of the plastic lifecycle, from extraction of fossil fuels, to consumer use, to disposal and beyond." Continue reading -> WHO Names Members Of Advisory Committee On Human Genome Editing 14/02/2019 David Branigan The World Health Organization today announced the membership of its advisory committee that will assist in the development of global standards for the governance and oversight of human genome editing. Continue reading -> New US Corporate Accountability Platform Takes Aim At High Drug Prices 13/02/2019 David Branigan A new corporate accountability platform launched in the United States aims to hold companies accountable by inviting shareholders and consumers to vote on how companies should address issues of the public interest. As its inaugural issue, the platform takes aim at high drug prices. Continue reading -> New Funding Partnership To Develop Innovative Drugs For Leishmaniasis 05/02/2019 David Branigan Wellcome has committed to provide more than £10 million to the Drugs for Neglected Diseases initiative (DNDi) over three years to develop new oral treatments for leishmaniasis, a devastating parasitic disease that primarily affects some of the world’s poorest people. Continue reading -> Beat NCDs: Rwanda Celebrates First Car-Free Day, While Kenya Plans Air Pollution Sensors 04/02/2019 Elaine Ruth Fletcher Rwanda’s capital city, Kigali, celebrated its first car-free day today, while a Kenyan telecom company was reported to have launched a major initiative to install 3,000 low-cost air pollution sensors around the country, in response to growing fears about air pollution’s health impacts. Continue reading -> Board Debates Medicines Access; WHO Asserts Mandate On IP, Trade Issues 30/01/2019 Catherine Saez Shortages, faulty supply chains, unbearable prices, weak health systems - the issue of access to medicines is multifaceted and gave way to a long list of interventions yesterday at the World Health Organization. Challenged on its mandate to address intellectual property and trade issues, WHO Director General Tedros Adhanom Gheyebresus (Dr Tedros) confirmed that WHO’s mandate includes work with partners on those issues. Discussions also included fair pricing and transparency, for which Italy called for a resolution at the next World Health Assembly. Continue reading -> Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Directors Meet With Staff This Week On Agency Transformation 25/02/2019 William New [Note: this meeting has been postponed until 6 March] Top officials from the World Health Organization will meet on 28 February will staff to discuss the transformation of the UN agency to a new structural alignment, according to an internal WHO email from the director general. Continue reading -> Suzette Kox Named Secretary General Of International Generic And Biosimilar Medicines Association 22/02/2019 William New The Geneva-based International Generic and Biosimilar medicines Association (IGBA) has named industry veteran Suzette Kox as secretary general. Image Credits: International Generic and Biosimilar medicines Association. Continue reading -> Report Details Health Crisis Hidden In Plastics Lifecycle 19/02/2019 William New A new report released today and authored by a range of environment and health groups pulls together research that "exposes distinct toxic risks plastic poses to human health at every stage of the plastic lifecycle, from extraction of fossil fuels, to consumer use, to disposal and beyond." Continue reading -> WHO Names Members Of Advisory Committee On Human Genome Editing 14/02/2019 David Branigan The World Health Organization today announced the membership of its advisory committee that will assist in the development of global standards for the governance and oversight of human genome editing. Continue reading -> New US Corporate Accountability Platform Takes Aim At High Drug Prices 13/02/2019 David Branigan A new corporate accountability platform launched in the United States aims to hold companies accountable by inviting shareholders and consumers to vote on how companies should address issues of the public interest. As its inaugural issue, the platform takes aim at high drug prices. Continue reading -> New Funding Partnership To Develop Innovative Drugs For Leishmaniasis 05/02/2019 David Branigan Wellcome has committed to provide more than £10 million to the Drugs for Neglected Diseases initiative (DNDi) over three years to develop new oral treatments for leishmaniasis, a devastating parasitic disease that primarily affects some of the world’s poorest people. Continue reading -> Beat NCDs: Rwanda Celebrates First Car-Free Day, While Kenya Plans Air Pollution Sensors 04/02/2019 Elaine Ruth Fletcher Rwanda’s capital city, Kigali, celebrated its first car-free day today, while a Kenyan telecom company was reported to have launched a major initiative to install 3,000 low-cost air pollution sensors around the country, in response to growing fears about air pollution’s health impacts. Continue reading -> Board Debates Medicines Access; WHO Asserts Mandate On IP, Trade Issues 30/01/2019 Catherine Saez Shortages, faulty supply chains, unbearable prices, weak health systems - the issue of access to medicines is multifaceted and gave way to a long list of interventions yesterday at the World Health Organization. Challenged on its mandate to address intellectual property and trade issues, WHO Director General Tedros Adhanom Gheyebresus (Dr Tedros) confirmed that WHO’s mandate includes work with partners on those issues. Discussions also included fair pricing and transparency, for which Italy called for a resolution at the next World Health Assembly. Continue reading -> Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Suzette Kox Named Secretary General Of International Generic And Biosimilar Medicines Association 22/02/2019 William New The Geneva-based International Generic and Biosimilar medicines Association (IGBA) has named industry veteran Suzette Kox as secretary general. Image Credits: International Generic and Biosimilar medicines Association. Continue reading -> Report Details Health Crisis Hidden In Plastics Lifecycle 19/02/2019 William New A new report released today and authored by a range of environment and health groups pulls together research that "exposes distinct toxic risks plastic poses to human health at every stage of the plastic lifecycle, from extraction of fossil fuels, to consumer use, to disposal and beyond." Continue reading -> WHO Names Members Of Advisory Committee On Human Genome Editing 14/02/2019 David Branigan The World Health Organization today announced the membership of its advisory committee that will assist in the development of global standards for the governance and oversight of human genome editing. Continue reading -> New US Corporate Accountability Platform Takes Aim At High Drug Prices 13/02/2019 David Branigan A new corporate accountability platform launched in the United States aims to hold companies accountable by inviting shareholders and consumers to vote on how companies should address issues of the public interest. As its inaugural issue, the platform takes aim at high drug prices. Continue reading -> New Funding Partnership To Develop Innovative Drugs For Leishmaniasis 05/02/2019 David Branigan Wellcome has committed to provide more than £10 million to the Drugs for Neglected Diseases initiative (DNDi) over three years to develop new oral treatments for leishmaniasis, a devastating parasitic disease that primarily affects some of the world’s poorest people. Continue reading -> Beat NCDs: Rwanda Celebrates First Car-Free Day, While Kenya Plans Air Pollution Sensors 04/02/2019 Elaine Ruth Fletcher Rwanda’s capital city, Kigali, celebrated its first car-free day today, while a Kenyan telecom company was reported to have launched a major initiative to install 3,000 low-cost air pollution sensors around the country, in response to growing fears about air pollution’s health impacts. Continue reading -> Board Debates Medicines Access; WHO Asserts Mandate On IP, Trade Issues 30/01/2019 Catherine Saez Shortages, faulty supply chains, unbearable prices, weak health systems - the issue of access to medicines is multifaceted and gave way to a long list of interventions yesterday at the World Health Organization. Challenged on its mandate to address intellectual property and trade issues, WHO Director General Tedros Adhanom Gheyebresus (Dr Tedros) confirmed that WHO’s mandate includes work with partners on those issues. Discussions also included fair pricing and transparency, for which Italy called for a resolution at the next World Health Assembly. Continue reading -> Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Report Details Health Crisis Hidden In Plastics Lifecycle 19/02/2019 William New A new report released today and authored by a range of environment and health groups pulls together research that "exposes distinct toxic risks plastic poses to human health at every stage of the plastic lifecycle, from extraction of fossil fuels, to consumer use, to disposal and beyond." Continue reading -> WHO Names Members Of Advisory Committee On Human Genome Editing 14/02/2019 David Branigan The World Health Organization today announced the membership of its advisory committee that will assist in the development of global standards for the governance and oversight of human genome editing. Continue reading -> New US Corporate Accountability Platform Takes Aim At High Drug Prices 13/02/2019 David Branigan A new corporate accountability platform launched in the United States aims to hold companies accountable by inviting shareholders and consumers to vote on how companies should address issues of the public interest. As its inaugural issue, the platform takes aim at high drug prices. Continue reading -> New Funding Partnership To Develop Innovative Drugs For Leishmaniasis 05/02/2019 David Branigan Wellcome has committed to provide more than £10 million to the Drugs for Neglected Diseases initiative (DNDi) over three years to develop new oral treatments for leishmaniasis, a devastating parasitic disease that primarily affects some of the world’s poorest people. Continue reading -> Beat NCDs: Rwanda Celebrates First Car-Free Day, While Kenya Plans Air Pollution Sensors 04/02/2019 Elaine Ruth Fletcher Rwanda’s capital city, Kigali, celebrated its first car-free day today, while a Kenyan telecom company was reported to have launched a major initiative to install 3,000 low-cost air pollution sensors around the country, in response to growing fears about air pollution’s health impacts. Continue reading -> Board Debates Medicines Access; WHO Asserts Mandate On IP, Trade Issues 30/01/2019 Catherine Saez Shortages, faulty supply chains, unbearable prices, weak health systems - the issue of access to medicines is multifaceted and gave way to a long list of interventions yesterday at the World Health Organization. Challenged on its mandate to address intellectual property and trade issues, WHO Director General Tedros Adhanom Gheyebresus (Dr Tedros) confirmed that WHO’s mandate includes work with partners on those issues. Discussions also included fair pricing and transparency, for which Italy called for a resolution at the next World Health Assembly. Continue reading -> Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Names Members Of Advisory Committee On Human Genome Editing 14/02/2019 David Branigan The World Health Organization today announced the membership of its advisory committee that will assist in the development of global standards for the governance and oversight of human genome editing. Continue reading -> New US Corporate Accountability Platform Takes Aim At High Drug Prices 13/02/2019 David Branigan A new corporate accountability platform launched in the United States aims to hold companies accountable by inviting shareholders and consumers to vote on how companies should address issues of the public interest. As its inaugural issue, the platform takes aim at high drug prices. Continue reading -> New Funding Partnership To Develop Innovative Drugs For Leishmaniasis 05/02/2019 David Branigan Wellcome has committed to provide more than £10 million to the Drugs for Neglected Diseases initiative (DNDi) over three years to develop new oral treatments for leishmaniasis, a devastating parasitic disease that primarily affects some of the world’s poorest people. Continue reading -> Beat NCDs: Rwanda Celebrates First Car-Free Day, While Kenya Plans Air Pollution Sensors 04/02/2019 Elaine Ruth Fletcher Rwanda’s capital city, Kigali, celebrated its first car-free day today, while a Kenyan telecom company was reported to have launched a major initiative to install 3,000 low-cost air pollution sensors around the country, in response to growing fears about air pollution’s health impacts. Continue reading -> Board Debates Medicines Access; WHO Asserts Mandate On IP, Trade Issues 30/01/2019 Catherine Saez Shortages, faulty supply chains, unbearable prices, weak health systems - the issue of access to medicines is multifaceted and gave way to a long list of interventions yesterday at the World Health Organization. Challenged on its mandate to address intellectual property and trade issues, WHO Director General Tedros Adhanom Gheyebresus (Dr Tedros) confirmed that WHO’s mandate includes work with partners on those issues. Discussions also included fair pricing and transparency, for which Italy called for a resolution at the next World Health Assembly. Continue reading -> Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New US Corporate Accountability Platform Takes Aim At High Drug Prices 13/02/2019 David Branigan A new corporate accountability platform launched in the United States aims to hold companies accountable by inviting shareholders and consumers to vote on how companies should address issues of the public interest. As its inaugural issue, the platform takes aim at high drug prices. Continue reading -> New Funding Partnership To Develop Innovative Drugs For Leishmaniasis 05/02/2019 David Branigan Wellcome has committed to provide more than £10 million to the Drugs for Neglected Diseases initiative (DNDi) over three years to develop new oral treatments for leishmaniasis, a devastating parasitic disease that primarily affects some of the world’s poorest people. Continue reading -> Beat NCDs: Rwanda Celebrates First Car-Free Day, While Kenya Plans Air Pollution Sensors 04/02/2019 Elaine Ruth Fletcher Rwanda’s capital city, Kigali, celebrated its first car-free day today, while a Kenyan telecom company was reported to have launched a major initiative to install 3,000 low-cost air pollution sensors around the country, in response to growing fears about air pollution’s health impacts. Continue reading -> Board Debates Medicines Access; WHO Asserts Mandate On IP, Trade Issues 30/01/2019 Catherine Saez Shortages, faulty supply chains, unbearable prices, weak health systems - the issue of access to medicines is multifaceted and gave way to a long list of interventions yesterday at the World Health Organization. Challenged on its mandate to address intellectual property and trade issues, WHO Director General Tedros Adhanom Gheyebresus (Dr Tedros) confirmed that WHO’s mandate includes work with partners on those issues. Discussions also included fair pricing and transparency, for which Italy called for a resolution at the next World Health Assembly. Continue reading -> Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New Funding Partnership To Develop Innovative Drugs For Leishmaniasis 05/02/2019 David Branigan Wellcome has committed to provide more than £10 million to the Drugs for Neglected Diseases initiative (DNDi) over three years to develop new oral treatments for leishmaniasis, a devastating parasitic disease that primarily affects some of the world’s poorest people. Continue reading -> Beat NCDs: Rwanda Celebrates First Car-Free Day, While Kenya Plans Air Pollution Sensors 04/02/2019 Elaine Ruth Fletcher Rwanda’s capital city, Kigali, celebrated its first car-free day today, while a Kenyan telecom company was reported to have launched a major initiative to install 3,000 low-cost air pollution sensors around the country, in response to growing fears about air pollution’s health impacts. Continue reading -> Board Debates Medicines Access; WHO Asserts Mandate On IP, Trade Issues 30/01/2019 Catherine Saez Shortages, faulty supply chains, unbearable prices, weak health systems - the issue of access to medicines is multifaceted and gave way to a long list of interventions yesterday at the World Health Organization. Challenged on its mandate to address intellectual property and trade issues, WHO Director General Tedros Adhanom Gheyebresus (Dr Tedros) confirmed that WHO’s mandate includes work with partners on those issues. Discussions also included fair pricing and transparency, for which Italy called for a resolution at the next World Health Assembly. Continue reading -> Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Beat NCDs: Rwanda Celebrates First Car-Free Day, While Kenya Plans Air Pollution Sensors 04/02/2019 Elaine Ruth Fletcher Rwanda’s capital city, Kigali, celebrated its first car-free day today, while a Kenyan telecom company was reported to have launched a major initiative to install 3,000 low-cost air pollution sensors around the country, in response to growing fears about air pollution’s health impacts. Continue reading -> Board Debates Medicines Access; WHO Asserts Mandate On IP, Trade Issues 30/01/2019 Catherine Saez Shortages, faulty supply chains, unbearable prices, weak health systems - the issue of access to medicines is multifaceted and gave way to a long list of interventions yesterday at the World Health Organization. Challenged on its mandate to address intellectual property and trade issues, WHO Director General Tedros Adhanom Gheyebresus (Dr Tedros) confirmed that WHO’s mandate includes work with partners on those issues. Discussions also included fair pricing and transparency, for which Italy called for a resolution at the next World Health Assembly. Continue reading -> Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Board Debates Medicines Access; WHO Asserts Mandate On IP, Trade Issues 30/01/2019 Catherine Saez Shortages, faulty supply chains, unbearable prices, weak health systems - the issue of access to medicines is multifaceted and gave way to a long list of interventions yesterday at the World Health Organization. Challenged on its mandate to address intellectual property and trade issues, WHO Director General Tedros Adhanom Gheyebresus (Dr Tedros) confirmed that WHO’s mandate includes work with partners on those issues. Discussions also included fair pricing and transparency, for which Italy called for a resolution at the next World Health Assembly. Continue reading -> Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Breaking News: WHO Board Completes Work On Access To Medicines Roadmap 29/01/2019 Catherine Saez After 65 interventions by member states and non-governmental organisations, at press time the World Health Organization Executive Board concluded work on a document containing a draft roadmap to increase access to medicines and vaccines. Continue reading -> Posts navigation Older Posts Newer Posts